Centessa Pharmaceuticals plc
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
15.00 |
13.75 |
3.78 |
40.90 |
134.83 |
386.97 |
| Przychód Δ r/r |
0.00% |
-8.33% |
-72.51% |
982.01% |
229.67% |
187.00% |
| Przychód (min) |
15.00 |
13.75 |
3.78 |
40.90 |
134.83 |
386.97 |
| Przychód (max) |
15.00 |
13.75 |
3.78 |
40.90 |
134.83 |
386.97 |
| EBITDA (średnia) |
9.00 |
8.25 |
2.27 |
24.54 |
80.90 |
232.18 |
| EBIT (średnia) |
9.00 |
8.25 |
2.27 |
24.54 |
80.90 |
232.18 |
| EBIT % |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-183.91 |
-146.05 |
-170.29 |
-175.24 |
-133.93 |
21.42 |
| Zysk netto % |
-1226.09% |
-1062.18% |
-4504.92% |
-428.45% |
-99.33% |
5.54% |
| EPS (średnia) |
-1.53 |
-1.28 |
-1.49 |
-1.59 |
-1.17 |
0.19 |
| Liczba analityków (Przychody) |
6 |
12 |
11 |
10 |
4 |
5 |
| Liczba analityków (EPS) |
5 |
6 |
8 |
10 |
5 |
4 |
| symbol |
CNTA |
CNTA |
CNTA |
CNTA |
CNTA |
CNTA |